KPTI
Karyopharm Therapeutics Inc. · Healthcare
President and CEO Richard A. Paulson sold $116K of Karyopharm Therapeutics Inc.
Sold$116,311
$9.41Price
12,361Shares
−4%Stake
What KPTI did after the filing
- The stock from Tue, Mar 3 close, $9.13
- −6.2%
- S&P 500, same days
- +2.9%
Measured over 30 trading days, to the Apr 15 close.
Traded Mon, Mar 2. Filed Tue, Mar 3, 11:21 AM ET, during the session. Returns use the Mar 3 close and the Apr 15 close. Not investment advice.